| Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomerulopathy MM Hoffmann, H Scharnagl, E Panagiotou, WT Banghard, H Wieland, ... Journal of the American Society of Nephrology 12 (3), 524-530, 2001 | 59 | 2001 |
| A pragmatic approach to adverse outcome pathway development and evaluation T Svingen, DL Villeneuve, D Knapen, EM Panagiotou, MK Draskau, ... Toxicological Sciences 184 (2), 183-190, 2021 | 45 | 2021 |
| Roasted and green coffee extracts show antioxidant and cytotoxic activity in myoblast and endothelial cell lines in a cell specific manner A Priftis, EM Panagiotou, K Lakis, C Plika, M Halabalaki, G Ntasi, ... Food and Chemical Toxicology 114, 119-127, 2018 | 42 | 2018 |
| Phthalates, ovarian function and fertility in adulthood EM Panagiotou, V Ojasalo, P Damdimopoulou Best Practice & Research Clinical Endocrinology & Metabolism 35 (5), 101552, 2021 | 37 | 2021 |
| Identification of biomarkers and outcomes of endocrine disruption in human ovarian cortex using In Vitro Models T Li, P Vazakidou, PEG Leonards, A Damdimopoulos, EM Panagiotou, ... Toxicology 485, 153425, 2023 | 7 | 2023 |
| AOP key event relationship report: Linking decreased androgen receptor activation with decreased granulosa cell proliferation of gonadotropin-independent follicles EM Panagiotou, MK Draskau, T Li, A Hirschberg, T Svingen, ... Reproductive Toxicology 112, 136-147, 2022 | 5 | 2022 |
| Exposure to the phthalate metabolite MEHP impacts survival and growth of human ovarian follicles in vitro EM Panagiotou, A Damdimopoulos, T Li, E Moussaud-Lamodière, ... Toxicology 505, 153815, 2024 | 1 | 2024 |
| Adverse outcome pathway network for endocrine disruption targeting estrogen, androgen and steroidogensis modalities–aspects for methodology development J Zilliacus, MK Draskau, HK Johansson, AK Rosenmai, S Christiansen, ... Toxicology Letters 384 (Supplement 1), S77, 2023 | | 2023 |
| SOC-I-04 Identification of biomarkers and outcomes of endocrine disruption in adult human ovarian cortex T Li, P Vazakidou, P Leonards, A Damdimopoulou, EM Panagiotou, ... Toxicology Letters 368, S22, 2022 | | 2022 |
| KER2273 Development of AOP345: Linking decreased androgen receptor activation with decreased granulosa cell proliferation of gonadotropin-independent follicles EM Panagiotou, MK Draskau, T Li, AL Hirschberg, P Damdimopoulou, ... Toxicology Letters 368 (Supplement), S86-S86, 2022 | | 2022 |
| Molecular toxicity studies of green and roasted coffee extracts reveal cell and dose specific mode of action D Kouretas, A Priftis, AEA Terzidou, EM Panagiotou, M Halabalaki, ... Toxicology Letters 280, S317, 2017 | | 2017 |
| Apolipoprotein E-Sendai (Arg145→ Pro): Expression, Reinigung und Charakterisierung einer Apolipoprotein-E-Variante, die mit der Lipoprotein-Glomerulopathie assoziiert ist E Panagiotou Freiburg (Breisgau), Univ., Diss., 2003, 2001 | | 2001 |
| Pathophysiology of Renal Disease-Diminished LDL Receptor and High Heparin Binding of Apolipoprotein E2 Sendai Associated with Lipoprotein Glomerulopathy MM Hoffmann, H Scharnagl, E Panagiotou, WT Banghard, H Wieland, ... Journal of the American Society of Nephrology 12 (3), 524-530, 2001 | | 2001 |
| Characterisation of apolipoprotein E sendai, an apolipoprotein E variant associated with lipoprotein glomerulopathy MM Hoffmann, E Panagiotou, H Scharnagl, W Marz Atherosclerosis 151 (1), 267-267, 2000 | | 2000 |
